|
WO2021052140A1
|
|
Anticipatory learning method and system oriented towards short-term time series prediction
|
|
WO2021031991A1
|
|
Composition and method for treating hormone-dependent diseases and reducing drug tolerance of patients with hormone-dependent diseases
|
|
WO2021051256A1
|
|
Pancreatic pro-endocrine progenitor cells and use thereof
|
|
CN111808056A
|
|
Dopamine D2Receptor selective agonists and their use in the treatment of disease
|
|
CN111778213A
|
|
Method for inducing differentiated cells into multipotential endoderm stem cells and application thereof
|
|
CN111458511A
|
|
Atherosclerosis biomarker and application thereof
|
|
CN111458512A
|
|
Atherosclerosis biomarker and application thereof
|
|
CN111458513A
|
|
Atherosclerosis biomarker and application thereof
|
|
CN111334462A
|
|
Inhibition of EGF signaling pathway promotes end-maturation of parenchymal hepatocytes from endodermal stem cells
|
|
CN111394297A
|
|
Method for preparing functional hepatoblasts and liver parenchymal cells from endoderm stem cells in large scale and application of method
|
|
CN111656194A
|
|
Methods and compositions for TNBC compartmentalization and treatment
|
